Universidade de São Paulo (USP), Faculdade de Medicina (FM), Hospital das Clínicas (HC), Departamento de Pediatria, São Paulo, SP, Brazil.
Universidade de São Paulo (USP), Faculdade de Medicina (FM), Hospital das Clínicas (HC), Instituto da Criança, São Paulo, SP, Brazil.
J Pediatr (Rio J). 2019 Nov-Dec;95(6):667-673. doi: 10.1016/j.jped.2018.06.006. Epub 2018 Jul 19.
To evaluate mortality in adolescents and young adult patients with chronic diseases followed in a Latin American tertiary hospital.
A cross-sectional retrospective study was performed in a tertiary/academic hospital in the state of São Paulo, Brazil. Death occurred in 529/2850 (18.5%) adolescents and young adult patients with chronic diseases, and 25/529 (4.7%) were excluded due to incomplete medical charts. Therefore, 504 deaths were evaluated.
Deaths occurred in 316/504 (63%) of early adolescent patients and in 188/504 (37%) of late adolescent/young adult patients. Further comparisons between early adolescents (n=316) and late adolescent/young adult patients (n=188) with pediatric chronic diseases at the last hospitalization showed that the median disease duration (22.0 [0-173] vs. 43.0 [0-227] months, p<0.001) was significantly lower in early adolescents vs. late adolescent/young adult patients. The median number of previous hospitalizations was significantly lower in the former group (4.0 [1-45] vs. 6.0 [1-52], p<0.001), whereas the last hospitalization in intensive care unit was significantly higher (60% vs. 47%, p=0.003). Regarding supportive measures, palliative care was significantly lower in the younger group compared to the older group (33% vs. 43%, p=0.02). The frequencies of renal replacement therapy (22% vs. 13%, p=0.02), vasoactive agents (65% vs. 54%, p=0.01), and transfusion of blood products (75% vs. 66%, p=0.03) were significantly higher in the younger group. The five most important etiologies of pediatric chronic diseases were: neoplasias (54.2%), hepatic diseases/transplantation (10%), human immunodeficiency virus (5.9%), and childhood-onset systemic lupus erythematosus and juvenile idiopathic arthritis (4.9%). Autopsy was performed in 58/504 (11%), and discordance between clinical and postmortem diagnoses was evidenced in 24/58 (41.3%).
Almost 20% of deaths occurred in adolescents and young adults with distinct supportive care and severe disease patterns. Discordance between clinical diagnosis and autopsy was frequently observed.
评估在一家拉丁美洲三级医院接受治疗的青少年和青年慢性病患者的死亡率。
在巴西圣保罗州的一家三级/学术医院进行了一项横断面回顾性研究。在患有慢性疾病的 2850 名青少年和青年患者中,有 529 人(18.5%)死亡,其中 25 人(4.7%)因病历不完整而被排除在外。因此,共评估了 504 例死亡。
在 504 例死亡中,316 例(63%)发生在早期青少年患者中,188 例(37%)发生在晚期青少年/青年成人患者中。进一步比较最后一次住院时患有儿科慢性疾病的早期青少年患者(n=316)和晚期青少年/青年成年患者(n=188)发现,早期青少年患者的中位疾病持续时间(22.0[0-173] 个月)显著短于晚期青少年/青年成年患者(43.0[0-227] 个月,p<0.001)。前者的中位住院次数(4.0[1-45] 次)显著低于后者(6.0[1-52] 次,p<0.001),而前者最后一次住院在重症监护病房的比例显著更高(60% vs. 47%,p=0.003)。在支持性治疗方面,姑息治疗在年龄较小的组中明显低于年龄较大的组(33% vs. 43%,p=0.02)。年轻组肾替代治疗(22% vs. 13%,p=0.02)、血管活性药物(65% vs. 54%,p=0.01)和血制品输注(75% vs. 66%,p=0.03)的频率明显更高。儿科慢性疾病的五个最重要病因是:肿瘤(54.2%)、肝脏疾病/移植(10%)、人类免疫缺陷病毒(5.9%)、儿童发病的系统性红斑狼疮和青少年特发性关节炎(4.9%)。504 例中有 58 例行尸检(11%),尸检证实临床诊断与死后诊断不符的有 24 例(41.3%)。
近 20%的死亡发生在具有不同支持性护理和严重疾病模式的青少年和青年中。临床诊断与尸检之间经常存在差异。